66results about How to "Ease the pain of treatment" patented technology

Disclosed is a sliding type multifunctional traction frame for lower limb skin traction which comprises a thigh support, a shank support, a fixed mount, a lifting lever, an adjusting device, a hauling cable, a bonding belt, a massage belt and an electric aerating device, wherein the shank support comprises a crossing member and a shank sliding tube, the shank sliding tube is provided with a traction rod, a connection rope is arranged between the thigh sliding tube and the shank sliding tube, the lower end of the lifting lever is connected with the adjusting device, the massage belt is placed on the outward surface of the suffered limbs, the massage belt and the suffered limbs are secured with the bonding belt, the massage belt can perform loose massage to the suffered limbs and prevent the common complication effectively.

The present invention is directed to an implantable drug depot useful for reducing, preventing or treating post-operative pain in a patient in need of such treatment, the implantable drug depot comprising a polymer and a therapeutically effective amount of a local anesthetic or pharmaceutically acceptable salt thereof, wherein the drug depot is implantable at a site beneath the skin to reduce, prevent or treat post-operative pain, and the drug depot is capable of releasing (i) a bolus dose of the local anesthetic or pharmaceutically acceptable salt thereof at a site beneath the skin and (ii) a sustained release dose of an effective amount of the local anesthetic or pharmaceutically acceptable salt thereof over a period of at least 4 days.

The invention discloses an application of berberine in medicine for treating or preventing influenza virus. The application proves that berberine enjoys the good function of resisting influenza virus on MDCK cells infected by A-type influenza virus such as H5N1 and H3N2 and on A549 cells.Meanwhile, the berberine can kill influenza virus to a certain extent, prevent attack from the influenza virusand inhibit cells infected by the influenza virus; the berberine enjoys similar effect to amantadine, a positive control medicine; in addition, the berberine can well inhibit inflammatory responses triggered by the influenza virus and is disclosed to enjoy the prospect of being developed into the medicine for resisting the influenza virus.

The invention discloses application of pomegranate in preparing a medicament for treating or preventing hepatitis B virus (HBV) infection. The application is implemented through the following steps: detecting the cytotoxicity of each pomegranate sourced medicament to HepG2.117, wherein the CC50 of punicalagin, gallic acid and punicalin is sequentially more than 500mu M, 334mu M and 218.86mu M; and then detecting the effects of the punicalagin, ellagic acid, gallic acid and punicalin to HBeAg and HBsAg, and the effect of punicalagin to DNA (deoxyribonucleic acid) and RNA (ribonucleic acid) of virus. Results indicate that the four compounds can be used for inhibiting HBeAg and HBsAg, wherein the punicalagin can be used for remarkably reducing the cccDNA (covalently closed circular DNA). The punicalagin can be used for remarkably reducing the contents of HBeAg and cccDNA in an HepG2.2.15 cell, and does not have effect to the total HBV DNA in the cell, which indicates that the punicalagin takes the cccDNA as a target to directly clear the cccDNA in a liver cell. Currently, the anti-HBV infection medicament in clinical treatment cannot directly act on the cccDNA, and cannot completely remove the virus. Experiment results disclose that the medicament has the prospect of being developed into anti-HBV infection medicaments.

The invention provides a visual trachea cannula. The cannula comprises a cannula body and a cuff. The cannula body comprises a flexible patient end, a machine end and a cannula cavity extended from the patient end to the machine end. The cuff is installed at the flexible patient end, and connected with an inflating device. The cannula body is provided with a bevel opening. The inner wall of the cannula body extended along the near end of the bevel opening is provided with an accommodating cavity and a washing channel. The opening end of the accommodating cavity is aligned to the near end of the bevel opening. The washing channel is adjacent to and separated from the accommodating cavity. A camera device is installed in the accommodating cavity. The camera device is inwards retracted relative to the near end of the bevel opening. The washing channel is provided with a washing hole which faces to the camera device and is communicated with the accommodating cavity. The flexible advantageof the flexible patient end is reserved, and the visual effect is achieved. In addition, the effect of cleaning a camera is remarkable.

The invention relates to tumor noninvasive treatment equipment, in particular to ultrahigh frequency tumor treatment equipment which comprises an ultrahigh frequency transmitter, a reflector isolator, a radiator, a treatment table, a monitor, a shielding chamber and a computer management system, wherein, the radiator, treatment table and monitor are arranged in the shielding chamber; the ultrahigh frequency transmitter is connected with the reflector isolator through a radio frequency cable; the reflector isolator is connected with the radiator through the radio frequency cable; the monitor is arranged above the treatment table and is connected with the computer management system through a monitor cable; the computer management system is connected with the ultrahigh frequency transmitter through a data transmission cable. The output frequency of the ultrahigh frequency transmitter is the continuous wave of 430-460MHz. The equipment has the advantages of enhancing the efficacy of the medicines for suppressing specific tumors and enabling the electromagnetic waves to reach deeper lesion sites so as to achieve better treatment effects.

The invention discloses a sterile bag for puncture lavage of the knee joint cavity. The sterile bag for puncture lavage of the knee joint cavity comprises a sterile bag body, a sterile box and an isolation mechanism. The sterile box is wrapped in the sterile bag body, the isolation mechanism is positioned in the sterile box, and the box body is of a hollow structure; an upper cover is hinged to the box body and rotates along the edge of the side, close to an opening, of the box body, and a middle laminated board is connected with the box body slidably and positioned on the side, close to the opening, of the box body; a plurality of partition boards are fixedly connected with the box body and the middle laminated board separately and transversely and longitudinally staggered, and the box body and the middle laminated board are divided into a plurality of placing cavities; shaping sponges are fixedly connected with the box body and positioned on the side, close to the inner wall, of thebox body, a placing column is fixedly connected with the box body and positioned in the box body, and a disinfection sponge is fixedly connected with the placing column and positioned at the bottom ofthe placing column. Cotton swabs are placed in the placing column and used for separating, isolating and classifying medical instruments, correspondingly medical personnel can conveniently find and take the medical instruments, unnecessary waste of treatment time is reduced, and treatment pain of patients is reduced.

The invention discloses the application of berberine in medicament for treating hepatitis B virus infection. In the invention, adopting an HepG2.2.15 cell model for the in vitro selection of anti-hepatitis B virus medicine, preliminarily selecting the effect of the medicament by measuring the difference of HBeAg and HBsAg expression volumn in supernatant fluid of the cell after administration, andfurther determining the effectiveness of the medicine by studying the inhibitory effect of the HBV DNA reproduction level (ccc DNA) in the HepG2.2.15 cell by the medicament. Meanwhile, the influenceon the reproduction of the hepatitis B virus by the transcriptional level of the medicine is studied according to the activity inhibitory effect to HBV viral promoters by the medicine, and key HBV cis-regulatory elements sensitive to the antivirus medicine are found. A pivotal cellular signal transduction pathway possibly participating the transcription reproduction for inhibiting viruses by the medicine is analyzed and verified on the basis, the antivirus molecular mechanism of the medicament is further studied, and the medicament is indicated to be developed and applied to clinical treatmentas an anti-hepatitis B effective medicament.

The invention relates to the technical field of processing of absorbent cotton and discloses absorbent cotton gauze to promote wound healing. The absorbent cotton gauze is made with 37-39 parts of cotton fiber, 11-13 parts of algal carbon fiber, 7-9 parts of chitosan fiber, and 5-7 parts of titanium dioxide suspension. The absorbent cotton gauze has an antibacterial rate of up to 92.1%, can avoidwound infections, promote blood circulation and quicken wound healing, enables wound healing time to be shortened by 20-25%, and allows therapeutic pain in a patient to be evidently relieved. Cotton fiber is soaked to quickly soften the surface fat and colloidal component of the cotton fiber, thereby facilitating late treatment and improving cotton fiber smoothness; an enzyme complex is added to carry out high temperature ultrasound treatment, lipase and pectinase are added to the enzyme complex, the surface fat and colloidal component of the cotton fiber are removed in mute state, and cottonfiber damage and environmental damage due to the use of traditional defatting methods using strong acids and alkalis are avoided; the absorbent cotton gauze is green; cotton fiber strength is improved.

The invention discloses a cardiothoracic surgical closed nursing drainage device which comprises a liquid storage bottle. A sealing cover is arranged on the upper surface of the liquid storage bottle,an exhaust tube and a connecting tube are arranged on the upper surface of the sealing cover, an inspiration tube is arranged inside the exhaust tube, an inspiration barrel is arranged at the end, which is far away from the exhaust tube, of the inspiration tube, a rubber plug is arranged inside the inspiration barrel, the outer side surface of the rubber plug is in contact with the inner side surface of the inspiration barrel, a push handle is arranged on the rear surface of the rubber plug, and a push plate is arranged at the end, which is far away from the rubber plug, of the push handle. The cardiothoracic surgical closed nursing drainage device has the advantages that the cardiothoracic surgical closed nursing drainage device is simple in structure, can be reliably fixed and is safe and hygienic; treatment suffering can be relieved for patients to a great extent, and the cardiothoracic surgical closed nursing drainage device can bring convenience in use; the cardiothoracic surgical closed nursing drainage device can be adhered on the skin of the patients without adhesive tapes, and accordingly skin allergy of the patients can be completely eradicated; a first air bag can be pinched, accordingly, air in the first air bag can be delivered into a second air bag via an air inlet tube, and a drainage tube can be conveniently fixed.

The invention discloses application of usnic acid (UA) in anti-influenza virus medicaments. The invention shows that the usnic acid has a certain anti-influenza virus function in vitro on MDCK cells and A549 cells infected by influenza A viruses, such as H5N1, H3N2 and the like. The impact effect of the medicaments applying the usnic acid relatively approaches that of a positive control medicament, namely amantadine; in addition, the usnic acid has better inhibiting effect on inflammatory reaction induced by the influenza viruses, which exposes that the medicaments applying the usnic acid have the prospect of being developed into anti-influenza virus medicaments.

The invention discloses an integrated penetrating therapy device for otorhinolaryngological department. The device structurally comprises a device main body, a control panel, a telescopic adjusting support frame, a probe fixing frame, a penetrating therapy head, a connecting line and a telescopic adjusting control mechanism, wherein the telescopic adjusting support frame is perpendicularly connected to the backmost part of the surface of the upper end of the device main body and runs through the interior of the device main body; and the telescopic adjusting control mechanism is movably connected to the left side of an inner cavity of the device main body. The penetrating therapy device provided by the invention, in a process of conducting a penetrating therapy operation on a patient of otorhinolaryngological department, is time-saving and labor-saving and is scientific and convenient, and moreover, the support frame part of the penetrating head of the equipment (the penetrating therapydevice) can undergo certain telescopic adjusting treatment in accordance with an actual penetrating therapy requirement of the patient, so that the pertinence and effect of penetrating therapy can beachieved as expected, workload as well as diagnosis and treatment difficulty of medical personnel can be reduced, treatment pain of the patient of otorhinolaryngological department can be also relieved and the reliability of the equipment can be effectively improved.

The invention discloses a eustachian tube irrigation-dilation drug delivery integrated device and a using method thereof. An irrigation dilator of a combined stent is clamped in a front outer clampingtube of a conveying system and is driven to advance through a rear driving portion, a water guide tube inner core of the irrigation dilator is connected to the interior of an outer annular water guide tube in a sleeving manner, the tail of the water guide tube inner core and the tail of the outer annular water guide tube are connected with an outlet A and an outlet B of a medical three-way valvethrough guide tubes respectively, an inlet of the medical three-way valve is connected with a water injection device or a lavage device, and a eustachian tube drug stent is telescopically connected tothe exterior of a balloon body in a sleeving mode. According to the eustachian tube irrigation-dilation drug delivery integrated device and the using method thereof, a balloon dilation guide tube, the water guide tube inner core and the eustachian tube drug stent are integrated, the whole device is pushed at a time through the conveying system in use, cleaning and dilation drug delivery treatmentof the eustachian tube can be achieved only by externally exchanging the inlet of the medical three-way valve to be connected with the lavage device or the water injection device, balloon dilation and eustachian tube drug stent releasing are synchronously completed, the device is easy to operate, safety and reliability are achieved, and the treatment scheme is more perfect.

The invention discloses a built-in chemoradiotherapy pump for the oncology department. The chemoradiotherapy pump comprises a shell, medicine storage tanks, a medicine conveying device and a medicinebag. The shell is internally provided with a liquid medicine chamber and an electric appliance chamber, a partition plate is reserved between the liquid medicine chamber and the electric appliance chamber, a groove is formed in the top end of the shell, and a timer and an indicator lamp are installed in the groove; the number of the medicine storage tanks is two, one medicine storage tank is a radiotherapy medicine tank, the other is a chemotherapy medicine tank, the bottom end of each medicine storage tank is connected to a medicine inlet pipe, the end of the medicine inlet pipe is communicated with the liquid medicine chamber through a medicine conveying pipe, an opening and closing valve is arranged on the side face of the medicine inlet pipe, and a second one-way valve is arranged on the medicine conveying pipe; and the medicine conveying device comprises an electric push rod and a piston plate, the electric push rod is fixed in the electric appliance chamber, an output shaft of the electric push rod is in sliding connection with the partition plate between the electric appliance chamber and the liquid medicine chamber, and the end of the output shaft is connected to the pistonplate. The chemoradiotherapy pump is high in functionality and capable of accurately controlling the conveying amount and conveying efficiency of medicines.

The invention discloses a pharmaceutical preparation for treating liver disease. The pharmaceutical preparation comprises, by weight, 9-11 parts of radix astragali, 2.5-3.5 parts of fructus lycii, 3.5-4.5 parts of herba hyperici japonici, 0.8-1.2 parts of borneol, 2.5-3.5 parts of spreading hedyotis herb, 5-7 parts of sparganium stoloniferum, 5-7 parts of rhizoma zedoariae, 3.5-4.5 parts of rhizoma alismatis, 7-9 parts of rhizoma polygoni cuspidati, 2.5-3.5 parts of radix bupleuri, 3.5-4.5 parts of radix salviae miltiorrhizae, 5-7 parts of fructus chaenomelis lagenariae and 0.8-1.2 parts of indigo naturalis. The pharmaceutical preparation for treating the liver disease has no toxic and side effects, and the curative effect is remarkable. The invention also discloses a preparation method ofthe pharmaceutical preparation for treating the liver diseases. The method includes the steps of weighing the raw materials; removes impurities, and cleanly processing the raw materials; pulverizingthe raw materials to 90-110 mesh and conducting screening to obtain fine powder; mixing the fine powder with borneol and then conducting grinding to obtain 90-110 mesh powder; mixing the obtained powder with indigo naturalis and then conducting grinding to obtain 90-110 mesh powder; preparing masterbatch; preparing pills and conducting drying; packing the dried pills and sending the packed pills to a sterilization room for sterilization and disinfection for 12 hours. The preparation method is simple, the drug efficacy is ensured, and the production cost is reduced.

The invention discloses an application of Lanosta-7,9(11),24-trien-3-one 15,26-dihydroxy in preparation of medicaments for preventing and/or treating enterovirus 71 infection. The invention confirms that the Lanosta-7,9(11),24-trien-3-one 15,26-dihydroxy has good antiviral effect in in-vitro enterovirus 71 (EV 71) infection cell tests. Meanwhile, the Lanosta-7,9(11),24-trien-3-one 15,26-dihydroxyhas certain killing effect on enterovirus 71 (EV 71), can prevent enterovirus 71 (EV 71) infection, has good treating effect on enterovirus 71 (EV 71) infected cells, has good inhibition effect on viral replication, and has more significant effect than a positive control medicament of ribavirin. In addition, the Lanosta-7,9(11),24-trien-3-one 15,26-dihydroxy has good inhibition effect on inflammation responses caused by enterovirus 71 (EV 71), which reveals that the Lanosta-7,9(11),24-trien-3-one 15,26-dihydroxy has the prospect of being developed into anti-enterovirus 71 (EV 71) medicaments.

The invention relates to a multifunctional device for removing intracranial hematoma, belonging to the technical field of medical devices for removing intracranial hematoma. It consists of a device body, a guide rod and a visual device. A water injection tube, a drug injection tube and two drainage fluid suction tubes are made in the cylindrical wall of the device body. The four tubes are arranged on the circumference of the device body. It is evenly distributed at 90°, and the bottom of the device body is made with a spraying inclined hole and a central through hole, and is equipped with two lighting devices; when the guide rod is pulled out of the device body, a visual device connected to the computer terminal can be installed in the cylinder . The present invention integrates blood clot pulverization, blood suction, flushing and drainage, medicine injection and illumination into one body, and one device can complete hematoma removal operation during operation, can effectively reduce intracranial pressure, and has short operation time. It solves the problem that the existing minimally invasive clearing device has single function, takes a long time to operate, and the clearing device has no lighting function, and cannot detect cerebrovascular lesions early, leaving patients with future problems.

The invention discloses necrotic-tissue-eliminating and granulation-promoting powder for wound regeneration and repair as well as a preparation method and an application method. The necrotic-tissue-eliminating and granulation-promoting powder is prepared by the following traditional Chinese medicine materials of radix astragali, licorice roots, frankincense, myrrh, radix trichosanthis, radix salviae miltiorrhizae, angelica dahurica, Japanese ampelopsis roots, honeysuckle flowers and musk. The invention further discloses the preparation method of the necrotic-tissue-eliminating and granulation-promoting powder for the wound regeneration and the repair. The preparation method comprises the following steps of drying the radix astragali, the licorice roots, the frankincense, the myrrh, the radix trichosanthis, the radix salviae miltiorrhizae, the angelica dahurica, the Japanese ampelopsis root, the honeysuckle flowers and the musk, and separately pulverizing the dried traditional Chinese medicine materials to be 300 meshes or above; weighting the pulverized materials according to a certain formula; and uniformly mixing the weighted materials, so as to obtain the necrotic-tissue-eliminating and granulation-promoting powder for the wound regeneration and the repair. The necrotic-tissue-eliminating and granulation-promoting powder for the wound regeneration and the repair has the effects of being antibacterial, diminishing inflammation, promoting wound to heal, and improving the immunologic function of organisms.

The invention discloses a combined hyperthermic perfusion drainage tube set and belongs to the field of medical apparatuses and instruments. The hyperthermic perfusion drainage tube set is divided into a drainage tube set body and a temperature measurement set, wherein an outer set is directly fixed to the center of a heparin cap film by using a temperature measurement wire, a disposable sterile temperature measurement sensor is inserted into a drainage tube wall sheath during treatment, a heparin cap is fixed, an external connector is directly connected with a hyperthermic perfusion machine,and the set can be directly removed after treatment. The drainage tube set is provided with a special temperature measurement sensor drainage tube wall sheath channel, original in-vitro indirect temperature measurement is changed into in-vivo direct temperature measurement for hyperthermic perfusion of the body cavity, the precision of temperature measurement in the body cavity during treatment inthe body cavity is greatly improved, and especially the influence of outside environment temperature on temperature measurement is completely eradicated, so that medical workers accurately master temperature change of the body cavity. The combined hyperthermic perfusion drainage tube set is simple in whole structure, easy to manufacture, low in cost and convenient to popularize widely.

The invention belongs to the field of medical instruments, and particularly relates to a device for preventing anastomotic stoma stenosis after esophageal surgery of children. The device comprises a tube body, wherein a cylindrical air bag is fixedly arranged outside the tube body in a sleeving mode, is attached to the outside of the tube body and extends in the axis direction of the tube body, an elastic sealing film is mounted on the inner wall of the tube body, a sealed tube barrel channel is formed by the elastic sealing film and the inner wall of the tube body, an adapter is mounted at the upper end of the tube body, a food injection opening connector and a sealing barrel are mounted on the adapter, the food injection opening connector communicates with the upper end of the tube body, a sealing barrel communicates with the cylindrical air bag through the tube barrel channel, and a piston plate is connected into the sealing barrel in a sealing and sliding manner. According to the device, air can be injected into the cylindrical air bag, a narrow esophageal anastomotic stoma can be expanded through tension of the cylindrical air bag, and a pressure monitoring mechanism is arranged, so that the danger that anastomotic mucosa is torn and esophagus perforation is caused due to the fact that pressure in the cylindrical air bag is too large can be avoided, control and operation are convenient, and cost is lower.

The invention discloses an external traditional Chinese medicine for treating cervical HPV (human papillomavirus) infection. The external traditional Chinese medicine is prepared from ninetraditionalchinese medicinal materials as follows: semen coicis, rhizoma bletillae, fructus mume, radix trichosanthis, Chinese medical stone, herba equiseti hiemalis, radix lithospermi, herba houttuyniae and radix isatidis. The invention further discloses a preparation method of the external traditional Chinese medicine. The external traditional Chinese medicine can kill or eliminate HPV of female genital parts, promote repair of local mucosa tissue and improve the immune function of a local mucosa microenvironment, and accordingly, and the purpose of treating the disease, reducing recurrence or preventing the disease is achieved; the external traditional Chinese medicine has the advantages of being convenient to use, high in cure rate, low in recurrence rate, small in toxic and side effect and the like.

The invention relates to the technical field of anti-tumour traditional Chinese medicines, in particular to a traditional Chinese medicine for treating bone tumour. According to the technical scheme, the formula of the traditional Chinese medicine comprises the following raw materials: codonopsis pilosula, radix stephaniae tetrandrae, concha arcae, kelp, slender dutchmanspipe root, astragalus membranaceus, lucid ganoderma, honeysuckle, radix ophiopogonis, scutellaria baicalensis, rehmannia root, glossy privet fruit, polyporus umbellatus, angelica sinensis, bezoar, dandelion, selfheal, buffalo horn, polygonum multiflorum, Chinese thorowax root, asparagus cochinchinensis, tuckahoe, hedyotis diffusa, Chinese lobelia herb, polysaccharide extract from mushrooms, glabrous sarcandra herb, paniculate swallowwort root, seaweed, pseudo-ginseng, parasitic loranthus, sweet wormwood, corn stigma, placenta hominis, rehmannia, agrimonia pilosa, cassia twig, liquorice, viola mandshurica, cornus officinalis, barbary wolfberry fruit, psoralea corylifolia and atractylodes. The traditional Chinese medicine has the advantages that the cost is low, the traditional Chinese medicine is convenient to take, the growth of a tumour can be inhibited, the treatment cost is low, the treatment pain of a patient is reduced, simultaneously, the immunity of the patient can be improved, the treatment effect is remarkable and the like.